Trial Profile
Clinical study for anlotinib monotherapy and anlotinib combined with vinorelbine in the second-line treatment of advanced lung squamous cell carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Catequentinib (Primary) ; Erlotinib; Vinorelbine
- Indications Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 10 Aug 2018 New trial record